Results Summary and Professional Abstract
|This project's final research report is expected to be available by March 2020.|
|Article Highlight: For patients who have surgery to remove colorectal tumors, reoccurrence of tumors is a major concern. Researchers in this study reported in JAMA that healthcare facilities that do more-frequent surveillance failed to detect recurring cancers any sooner than facilities that do less-frequent surveillance. The study, which analyzed data from more than 8,000 patients, also found no link between the intensity of surveillance and overall survival, suggesting more-frequent surveillance provided no health benefit.|
Studying the Frequency of Testing for Colorectal Cancer Survivors (right)
Principal Investigator George Chang discusses this project, which examined whether the frequency of follow-up testing of colorectal cancer survivors had an effect on the detection of recurrence or survival.
Benefits and Drawbacks of Cancer Surveillance
Principal Investigator George Chang shares some of the most common benefits and drawbacks of cancer surveillance, including patient anxiety.
How Frequently Should Cancer Survivors be Screened for Disease Recurrence? Is More Always Better?
In August 2019, the National Alliance of Healthcare Purchaser Coalitions hosted a webinar discussion about the frequency of testing and screening practices following surgery for colorectal cancer. The webinar featured George J. Chang, MD, MS, who discussed his findings’ possible impact for employers and influence on medical guidelines, and compared current US practices in relation to other countries.
Peer review of PCORI-funded research helps make sure the report presents complete, balanced, and useful information about the research. It also assesses how the project addressed PCORI’s Methodology Standards. During peer review, experts read a draft report of the research and provide comments about the report. These experts may include a scientist focused on the research topic, a specialist in research methods, a patient or caregiver, and a healthcare professional. These reviewers cannot have conflicts of interest with the study.
The peer reviewers point out where the draft report may need revision. For example, they may suggest ways to improve descriptions of the conduct of the study or to clarify the connection between results and conclusions. Sometimes, awardees revise their draft reports twice or more to address all of the reviewers’ comments.
Peer reviewers commented, and the researchers made changes or provided responses. The comments and responses included the following:
- The reviewers asked why the analyses did not connect the intensity of cancer surveillance at the individual patient level directly, rather than at the facility level. The researchers indicated that individual patients’ surveillance intensity typically was related to their risk of recurrence, thus leading to potential bias at the individual patient level.
- Since the study observed no difference in survival based on surveillance intensity, the reviewers said it would have been interesting to include patients who did not have any surveillance. The researchers said their study excluded patients who received no surveillance because that is not in line with recommended practice and is often associated with patient factors that could bias findings.
- The reviewers said it would be helpful to see an economic analysis of the difference between high-intensity and low-intensity surveillance facilities since the study implies that the low-intensity facilities provided similar quality of care more efficiently. The researchers said an economic analysis was beyond the scope of this study and would have been difficult to conduct given the lack of identifying information collected about patients. An analysis of costs to operate high- versus low-intensity surveillance facilities would also fall outside of PCORI’s restrictions on funding cost effectiveness research.
- The reviewers asked the researchers to justify combining colon and rectal cancer outcomes, since these are distinct diseases with different treatments and prognoses. The researchers said that despite the differences between them, the follow-up strategies for the two diseases are the same, and the two surveillance intensity groups had a balanced number of colon and rectal cancer patients.
Conflict of Interest Disclosures
View the COI disclosure form.